299018
Is Face-to-Face Meeting Superior to Virtual Review Meeting?
DESIGNS: The nine SEP sessions reviewed include five were face-to-face (FF) (GI) and four WebEx virtual reviews (VR (GII). Pre- and post-discussion scoring was recorded as usual. Thoroughness of the review is measured in terms of percentage and increments of score changes as well as length of discussion per application. Cost of each meeting has also been recorded.
RESULTS: There were 88 discussed applications in five FF sessions (GI: 17/session) compared to 52 applications in four VR sessions (GII: 13/session). FF sessions resulted in 73% (64/88) score changes (increase and decrease) compared to 60% (30/51) for virtual reviews (NS). Pre- to post-increases in scoring per application (group of three reviewers) are 1.85+/-1.00 and 2.00+/-1.34 for GI and II respectively (NS). Pre- to post-decreases in scoring per application are 1.58+/-0.79 and 1.12+/-0.35 for GI and GII respectively (NS). The incremental changes in scores are minimal and non-significant between the two groups. The time spent to review each application is 26 vs. 20 minutes for FF and VR, respectively. And the overall cost per reviewer is $1,000 higher for a FF than VR meeting.
CONCLUSIONS: FF and VR sessions resulted in:
- Non-significant percentage changes in scoring,
- Non-significant incremental changes in the degree of scoring,
- The cost of FF meeting is higher than VR, although time spent to review each application is not significantly different.
We conclude that the two methods are equally effective in evaluating grant applications.
Learning Areas:
Conduct evaluation related to programs, research, and other areas of practicePublic health administration or related administration
Public health or related education
Public health or related research
Learning Objectives:
Discuss face-to-face and Virtual review meetings.
Compare and evaluate the two types of meetings.
Keyword(s): Public Health Research, Outcomes Research
Qualified on the content I am responsible for because: I have been a Scientific Review Officer at AHRQ for many years and written many abstracts related to the scientific review process.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.